All In Biotech

Free tool

FAERS Monitor: Omnipaque 140

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 018956 or its brand name (Omnipaque 140, Iohexol). Reports on generic versions are filed under their own applications.

Reports

8,472

Serious

6,838

81% of reports

Hospitalization

2,772

Death reported

503

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • urticaria1,021
  • pruritus929
  • dyspnoea799
  • sneezing630
  • erythema586
  • nausea538
  • vomiting494
  • rash430
  • chills360
  • cough338
  • anaphylactic reaction322
  • acute kidney injury299
  • hypotension282
  • contrast media reaction270
  • pyrexia266

Reports by year received

View as table
YearReports
20047
200510
20065
20077
200811
20096
201013
201117
2012175
2013370
2014699
2015601
2016578
2017697
2018576
2019550
2020577
2021489
2022491
2023542
2024617
2025778
2026656

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,045,687 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
contrast media reactionSignal270320.6283.075,918
sneezingSignal63071.766.442,673
urticariaSignal1,02115.214.413,573
anaphylactic reactionSignal32214.513.14,036
chillsSignal3607.66.92,078
erythemaSignal5867.16.63,083
pruritusSignal9296.05.73,941
acute kidney injurySignal2994.94.3917
dyspnoeaSignal7993.53.31,467
hypotensionSignal2823.53.1504
coughSignal3383.02.7453
vomitingSignal4942.62.4500
rashSignal4302.52.2375
pyrexia2661.91.7116
nausea5381.71.6156

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.